May 7 2019
Allergan Fended Off Botox Rivalries In The First Quarter — But Can It Last?
Mizuho | Investor's Business Daily
May 3 2019
These 2 Drug Giants Beat Earnings Views; But Only One Entered Buy Range
Mizuho | Investor's Business Daily
May 2 2019
Is Gilead’s Former Golden Goose Stabilizing? Here’s What Earnings Say
Mizuho | Investor's Business Daily
May 2 2019
Sell-Side Bullish On Qualcomm After Quarterly Report; BofA Sees Growth Ahead In 5G
Mizuho | Benzinga
May 1 2019
Opposition May Grow to Occidental’s Anadarko Deal Because of Tough Berkshire Terms
Mizuho | Barron's